University Health Network
University Health Network
Toronto, Ontario, Canada11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, pyruvate kinase deficiency of red cells, sickle cell disease, thalassemia | Enrolling by invitation | Phase 4 | 2026-09-29 | NCT05777993 | |
| Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study) | primary sclerosing cholangitis | Recruiting | Not stated | 2026-09-08 | NCT06297993 | |
| The STOP-MED CTRCD Trial | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, cardiovascular disorder, heart disorder, heart failure, injury, neoplasm, radiation injury | Recruiting | Phase 4 | 2026-07-07 | NCT06183437 | |
| A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Active, not recruiting | Phase 2 / Phase 3 | 2026-06-23 | NCT05031780 | |
| CHARM-COPD Program of Care | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Not applicable | 2026-06-22 | NCT06253013 | |
| Nephrotic Syndrome Study Network | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, focal segmental glomerulosclerosis, glomerulonephritis, immune system disorder, kidney disorder, macular corneal dystrophy, membranous glomerulonephritis, minimal change disease, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Not stated | 2026-06-10 | NCT01209000 | |
| Feasibility of Early Swallowing and Speech Intervention for Head and Neck Cancer Patients Treated SURGically | Deglutition Disorders, Digestive System Diseases, Head and Neck Neoplasms, Neoplasms by Site, Pharyngeal Diseases, digestive system disorder, esophageal disorder, head and neck cancer, neoplasm, otorhinolaryngologic disease | Recruiting | Not applicable | 2026-06-03 | NCT06192771 | |
| The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, cardiovascular disorder, heart disorder, heart failure, injury, neoplasm, radiation injury | Recruiting | Not applicable | 2025-11-26 | NCT05023785 | |
| Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION] | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 2 | 2025-05-29 | NCT06216470 | |
| The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer | Head and Neck Neoplasms, Neoplasms by Site, Thyroid Nodule, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumor | Recruiting | Not applicable | 2025-04-16 | NCT06929650 | |
| Comprehensive Health Assessment for My Plan: Initial Implementation Study (CHAMP Implementation Study) | cancer, neoplasm | Recruiting | Not applicable | 2025-03-28 | NCT06464471 |